Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
de la Morena Barrio P, Conesa MÁ, González-Billalabeitia E, Urrego E, García-Garre E, García-Martínez E, Poves MZ, Vicente V, de la Peña FA. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Canc Netw. 2015 Apr;13(4):417-23. PubMed PMID: 25870378.
AÑO: 2015; IF: 4.262
Martínez C, Antón AI, Bernal A, Lozano ML, Ferrer-Marin F, Corral J, Iniesta JA, Vicente V, Rivera J. Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3. J Clin Neurol. 2015 Jan;11(1):102-3. doi: 10.3988/jcn.2015.11.1.102. PubMed PMID: 25628745; PubMed Central PMCID: PMC4302171.
AÑO: 2015; IF: 2.439
Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Am J Med. 2015 Nov;128(11):1237-43. doi: 10.1016/j.amjmed.2015.05.036. PubMed PMID: 26087049.
AÑO: 2015; IF: 5.61
Martínez-López J, Paiva B, López-Anglada L, Mateos MV, Cedena T, Vidríales MB, Sáez-Gómez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordón L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Bladé J, San Miguel JF, Lahuerta JJ; Spanish Multiple Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Group.. Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality. Blood. 2015 Aug 13;126(7):858-62. doi: 10.1182/blood-2015-04-638742. PubMed PMID: 26089396; PubMed Central PMCID: PMC4543912.
AÑO: 2015; IF: 11.847
Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, Perez M, Martinez R, de Paz R, Granell M, De Arriba F, Blanchard MJ, Peñalver FJ, Bello JL, Martin ML, Bargay J, Blade J, Lahuerta JJ, San Miguel JF, de la Rubia J. Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations. Leuk Res Rep. 2015 Sep 24;4(2):64-9. doi: 10.1016/j.lrr.2015.09.002. PubMed PMID: 26500850; PubMed Central PMCID: PMC4588395.
AÑO: 2015
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL